Search research articles
Contact Us
Filters
Showing results (21-30 of 376) with videos related to
Page
of 38
Sort By:
Journal of Colloid and Interface Science
|
March 21, 2013
Coacervates of lysozyme and β-casein
Skelte G Anema, C G Kees de Kruif
Current Cardiology Reports
|
October 21, 2015
New Approaches in Detection and Treatment of Familial Hypercholesterolemia
Merel L Hartgers, Kausik K Ray, G Kees Hovingh
Current Opinion in Lipidology
|
February 9, 2021
The clinical applicability of polygenic risk scores for LDL-cholesterol: considerations, current evidence and future perspectives
Arjen J Cupido, Tycho R Tromp, G Kees Hovingh
Journal of the American College of Cardiology
|
May 18, 2019
Hypercholesterolemia Among Premature Infarcts: Time to Start the Clock of Familial Hypercholesterolemia Assessment
G Kees Hovingh, Laurens F Reeskamp, Kausik K Ray
Atherosclerosis
|
October 2, 2018
Familial hypercholesterolemia treatments: Guidelines and new therapies
Frederick J Raal, G Kees Hovingh, Alberico L Catapano
The Canadian Journal of Cardiology
|
August 27, 2014
The value of screening for carotid plaque in patients referred for echocardiography
Raphael Duivenvoorden, Erik S G Stroes, G Kees Hovingh
Journal of Clinical Lipidology
|
May 17, 2017
Managing the challenging homozygous familial hypercholesterolemia patient: Academic insights and practical approaches for a severe dyslipidemia, a National Lipid Association Masters Summit
G Kees Hovingh, Anne C Goldberg, Patrick M Moriarty
Current Opinion in Lipidology
|
February 19, 2015
HDL re-examined
G Kees Hovingh, Daniel J Rader, Robert A Hegele
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 22, 2021
Letter by Tromp et al Regarding Article, "Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland"
Tycho R Tromp, G Kees Hovingh, Laurens F Reeskamp
Circulation
|
August 5, 2015
Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk? CETP as a Target to Lower CVD Risk: Suspension of Disbelief?
G Kees Hovingh, Kausik K Ray, S Matthijs Boekholdt
Page
of 38
Search research articles
Search
Showing results (21-30 of 376) with videos related to
Sort By:
Page
of 38
Journal of Colloid and Interface Science
|
March 21, 2013
Coacervates of lysozyme and β-casein
Skelte G Anema, C G Kees de Kruif
Current Cardiology Reports
|
October 21, 2015
New Approaches in Detection and Treatment of Familial Hypercholesterolemia
Merel L Hartgers, Kausik K Ray, G Kees Hovingh
Current Opinion in Lipidology
|
February 9, 2021
The clinical applicability of polygenic risk scores for LDL-cholesterol: considerations, current evidence and future perspectives
Arjen J Cupido, Tycho R Tromp, G Kees Hovingh
Journal of the American College of Cardiology
|
May 18, 2019
Hypercholesterolemia Among Premature Infarcts: Time to Start the Clock of Familial Hypercholesterolemia Assessment
G Kees Hovingh, Laurens F Reeskamp, Kausik K Ray
Atherosclerosis
|
October 2, 2018
Familial hypercholesterolemia treatments: Guidelines and new therapies
Frederick J Raal, G Kees Hovingh, Alberico L Catapano
The Canadian Journal of Cardiology
|
August 27, 2014
The value of screening for carotid plaque in patients referred for echocardiography
Raphael Duivenvoorden, Erik S G Stroes, G Kees Hovingh
Journal of Clinical Lipidology
|
May 17, 2017
Managing the challenging homozygous familial hypercholesterolemia patient: Academic insights and practical approaches for a severe dyslipidemia, a National Lipid Association Masters Summit
G Kees Hovingh, Anne C Goldberg, Patrick M Moriarty
Current Opinion in Lipidology
|
February 19, 2015
HDL re-examined
G Kees Hovingh, Daniel J Rader, Robert A Hegele
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 22, 2021
Letter by Tromp et al Regarding Article, "Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland"
Tycho R Tromp, G Kees Hovingh, Laurens F Reeskamp
Circulation
|
August 5, 2015
Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk? CETP as a Target to Lower CVD Risk: Suspension of Disbelief?
G Kees Hovingh, Kausik K Ray, S Matthijs Boekholdt
Page
of 38